Three claims that need three kinds of evidence
“Builds muscle and speeds recovery” sounds like one benefit. It actually combines several questions. Did a body-composition measurement change? Did people produce more force or perform daily tasks more easily? Did they recover sooner after a standardized workout or injury?
These outcomes are related, but one does not prove the others. A study that measures lean mass cannot answer a question about return to sport unless it measures return to sport. Similarly, an increase in a strength test does not tell us whether a tendon healed.
This distinction is especially useful when a provider discusses several benefits together. Ask which study supports each benefit. An accurate description can be encouraging about a narrow finding while leaving the broader claims unproven.
What a scan can and cannot tell you
| Outcome | Useful question | What it does not answer alone |
|---|---|---|
| Lean mass | Did measured nonfat tissue change? | Whether usable strength improved |
| Strength | Did force or a defined lifting task improve? | Whether an injury healed faster |
| Soreness | Did discomfort after a comparable session change? | Whether tissue repair accelerated |
| Return to activity | Could someone safely resume a defined activity sooner? | Whether every sport or injury would respond similarly |
To make a useful recovery claim, researchers need comparable exercise or injury conditions, a relevant control group, and predefined outcomes. A photograph or isolated hormone measurement cannot supply that comparison.
Deficiency treatment is not performance evidence
Growth hormone replacement can benefit appropriately diagnosed adults with growth hormone deficiency. That clinical context should not be quietly converted into proof that sermorelin improves performance in people without the condition.
The starting problem is different, the treatment is different, and the benefit being pursued may be different. A person with a documented endocrine disorder needs a clinical plan for that disorder. A person whose progress in the gym has slowed needs an evaluation that does not assume a hormonal explanation.
If a clinic cites an HGH paper during a sermorelin consultation, ask why it believes those results transfer to the proposed prescription. The sermorelin versus HGH comparison explains that distinction in more detail.
Make the goal concrete before judging progress
“Recover better” is difficult to evaluate. “Resume my clinician-approved activity without a flare-up” or “improve a specific functional limitation” is more concrete. Your clinician or rehabilitation professional can help define an outcome that fits the problem.
For exercise-related goals, keep track of changes to the training program and other treatment. If training volume drops at the same time a prescription starts, less soreness is not clear evidence of a drug effect. If several new supplements and medications begin together, attributing progress to one ingredient becomes harder.
Do not use this uncertainty as a reason to increase a dose or push through pain. It is a reason to review what is being measured and whether the original explanation still makes sense.
What to ask before paying for a recovery program
- Has this formulation been studied for my specific goal?
- Were the participants healthy athletes, older adults, or people with a diagnosed deficiency?
- Did the study measure strength or recovery directly?
- What role will rehabilitation, activity changes, and other care play?
- What would count as insufficient benefit to continue?
Compounded products also require a conversation about the dispensing pharmacy and instructions; FDA approval is not implied by a prescription. Review sermorelin safety before making a decision. The available findings leave room for research, but they do not establish a reliable muscle-recovery shortcut.
Sources & further reading
Sources reviewed October 2026. Provider prices and terms may change.